Phil Groom profile page

The threat from COVID-19 is receding and measures are being rolled back in many countries. In this opinion piece, Phil Groom argues that it's time to look at new diagnostic solutions in addition to vaccines.

Patient generated health data is a hot topic in healthcare, with connected technology driving a shift towards patient-centric care. Phil Groom argues that, after the pandemic, digitized lateral flow testing must become a key part of this movement.

Before 2020, the words “lateral flow” meant little to anyone outside the scientific community. Now, thanks to COVID-19, lateral flow is no longer an unknown. In this article, we explore the future of the technology.

Vaccination is the weapon that will ultimately defeat this pandemic, but getting there will take much time and effort. Until then there will still be a need for other measures to control the virus, including rapid diagnostic testing and screening.

This article takes a look at how people's expectations of connectivity in their everyday lives should inform how we approach medical diagnostic devices, and how connected, data-gathering tests could transform diagnostics, using the current pandemic as an example.

When it comes to testing for infectious diseases, it seems some companies are engaged in a “race to the bottom” to provide the cheapest test possible. Ever-lower price points might be attractive for cash-strapped governments, NGOs and charities engaged in the ongoing fight against infectious diseases, but are such practices putting us at risk of compromising quality?